Company profile
Neural Engineering | BIOS Health | United Kingdom
BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals. Beginning with cardiac conditions, BIOS envisions a new field of digital health treatments that use this new data-driven insight from the nervous system to create personalised, precision medicine.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
TM01 | Transaction MzQzOTkyMDY2M2FkaXF6a2N4 | Paper/PDF filed
Published 30 Oct 2024 07:09
Company registered at Companies House
1 Dec 2018 to 31 May 2020
CBAS is proposing to develop a Prosthetic Interface Device (PID): Digital, an innovative, continuous, system that aids in collecting data remotely for patients with mobility impairments: patients with lower limb disorders and vulnerable elderly people. PID: Digital takes advantage of the CBAS machine-learning (ML) platform. This system is used to collect ...
1 Aug 2017 to 31 Mar 2018
Cambridge Bio-Augmentation Systems (CBAS) is an award winning start-up, specialising in interfacing technologies for the integration of medical devices with the body. CBAS are developing a continuous remote monitoring system for use with medical devices, such as orthoses or prostheses, to enable real-time, remote assessment of activity, biomechanics and c...
